Merck Confident In Keytruda’s Dominance In Lung Cancer, Despite Competitors’ Data

 
• By Joseph Haas
Two leading hard currencies - US Dollar versus Euro
Keytruda's revenue topped $3bn during the third quarter

More from Earnings

More from Business